Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer
Citation
Wong , P-P , Yeoh , C C , Ahmad , A S , Chelala , C , Gillett , C , Speirs , V , Jones , J L & Hurst , H C 2014 , ' Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer ' , Oncogene , vol. 33 , no. 37 , pp. 4579-4588 . https://doi.org/10.1038/onc.2014.45
Rights
This work is licensed under a Creative Commons Attribution- NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
Related items
Showing items related by title, author, creator and subject.
-
Rare thyroid malignancies in Europe : data from the information network on rare cancers in Europe (RARECAREnet)
Locati, Laura; Cavalieri, Stefano; Maso, Luigino Dal; Busco, Susanna; Anderson, Lesley; Botta, Laura; Jose Bento, Maria; Carulla, Maria; Lopez, Maria Dolores Chirlaque; Fusco, Mario; Guevara, Marcela; Innos, Kaire; Johannesen, Tom Borge; Micallef, Rita; Minicozzi, Pamela; Panato, Chiara; Petrova, Dafina; Rubio-Casadevall, Jordi; Smailyte, Giedre; Vitale, Maria Francesca; Trama, Annalisa (2020-09) -
The IDENTIFY Study : The Investigation and Detection of Urological Neoplasia in Patients Referred with Suspected Urinary Tract Cancer; A multicentre observational study
Khadhouri, Sinan; Gallagher, Kevin M.; MacKenzie, Kenneth; Shah, Taimur T.; Gao, Chuanyu; Moore, Sacha; Zimmermann, Eleanor; Edison, Eric; Jefferies, Matthew; Nambiar, Arjun K.; Mannas, Miles; Lee , Taeweon; Marra , Giancarlo; Lillaz , Beatrice; Gómez Rivas, Juan; olivier, Jonathan; Assmus , Mark; Uçar, Taha; Claps, Francesco; Boltri , Matteo; Burnhope, Tara; Nkwam, Nkwam; Tanasescu, George; Boxall, Nicholas; Downey , Alison; Lal, Asim; Antón-Juanilla , Marta; Clarke, Holly; Lau, David; Gillams , Kathryn; Crockett, Matthew; Nielsen, Matthew E.; Takwoingi, Yemisi; Chuchu , Naomi; O'Rourke, John; MacLennan, Graeme; McGrath, John; Kasivisvanathan, Veeru; The IDENTIFY Study Group (2021-10-01) -
Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer
Ponnusamy, Suriyan; He, Yali; Hwang, Dong-Jin; Thiyagarajan, Thirumagal; Houtman, Rene; Bocharova, Vera; Sumpter, Bobby G.; Fernandez, Elias; Johnson, Daniel; Du, Ziyun; Pfeffer, Lawrence M.; Getzenberg, Robert H.; McEwan, Iain J.; Miller, Duane D.; Narayanan, Ramesh (2019-11)